{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:41:15Z","timestamp":1759412475159},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2013,10,4]],"date-time":"2013-10-04T00:00:00Z","timestamp":1380844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0074389","type":"journal-article","created":{"date-parts":[[2013,10,4]],"date-time":"2013-10-04T21:15:16Z","timestamp":1380921316000},"page":"e74389","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Non-Immunogenicity of Overlapping Gag Peptides Pulsed on Autologous Cells after Vaccination of HIV Infected Individuals"],"prefix":"10.1371","volume":"8","author":[{"given":"Henrik N.","family":"Kl\u00f8verpris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akil","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Handley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Gilmour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Riddell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Boffito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce D.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Ackland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Goulder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,10,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nri2674","article-title":"The immune response during acute HIV-1 infection: clues for vaccine development","volume":"10","author":"AJ McMichael","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.immuni.2012.09.005","article-title":"HIV and HLA Class I: An Evolving Relationship","volume":"37","author":"PJ Goulder","year":"2012","journal-title":"Immunity"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1128\/JVI.02438-09","article-title":"Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotype","volume":"84","author":"WL Dinges","year":"2010","journal-title":"J Virol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e29717","DOI":"10.1371\/journal.pone.0029717","article-title":"CTL Responses of High Functional Avidity and Broad Variant Cross-Reactivity Are Associated with HIV Control","volume":"7","author":"B Mothe","year":"2011","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm1520","article-title":"CD8+ T-cell responses to different HIV proteins have discordant associations with viral load","volume":"13","author":"P Kiepiela","year":"2007","journal-title":"Nat Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1128\/JVI.02073-08","article-title":"Differential neutralization of human immunodeficiency virus (HIV) replication in autologous CD4 T cells by HIV-specific cytotoxic T lymphocytes","volume":"83","author":"H Chen","year":"2009","journal-title":"J Virol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"7828","DOI":"10.4049\/jimmunol.0803928","article-title":"Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses","volume":"182","author":"A Saez-Cirion","year":"2009","journal-title":"J Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1128\/JVI.02131-12","article-title":"Early Antigen Presentation of Protective HIV-1 KF11Gag and KK10Gag Epitopes from Incoming Viral Particles Facilitates Rapid Recognition of Infected Cells by Specific CD8+ T Cells","volume":"87","author":"HN Kloverpris","year":"2013","journal-title":"J Virol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.4049\/jimmunol.178.5.2746","article-title":"Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression","volume":"178","author":"JB Sacha","year":"2007","journal-title":"J Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1128\/JVI.00068-08","article-title":"Multifunctional T-cell characteristics induced by a polyvalent DNA prime\/protein boost human immunodeficiency virus type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administration","volume":"82","author":"A Bansal","year":"2008","journal-title":"J Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1086\/509259","article-title":"Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine","volume":"194","author":"BS Graham","year":"2006","journal-title":"J Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1099\/vir.0.19701-0","article-title":"A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans","volume":"85","author":"M Mwau","year":"2004","journal-title":"J Gen Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/QAI.0b013e3180417cb6","article-title":"Safety and immunogenicity of a Gag-Pol candidate HIV-1 DNA vaccine administered by a needle-free device in HIV-1-seronegative subjects","volume":"44","author":"JA Tavel","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/415331a","article-title":"Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity","volume":"415","author":"JW Shiver","year":"2002","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"SP Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","article-title":"HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis","volume":"372","author":"MJ McElrath","year":"2008","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"115ra111","DOI":"10.1126\/scitranslmed.3003155","article-title":"Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man","volume":"4","author":"E Barnes","year":"2012","journal-title":"Sci Transl Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature10766","article-title":"Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys","volume":"482","author":"DH Barouch","year":"2011","journal-title":"Nature"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature10003","article-title":"Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine","volume":"473","author":"SG Hansen","year":"2011","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1128\/IAI.00740-09","article-title":"Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses","volume":"78","author":"A Reyes-Sandoval","year":"2010","journal-title":"Infect Immun"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2796.2008.02047.x","article-title":"Dendritic cell-based human immunodeficiency virus vaccine","volume":"265","author":"CR Rinaldo","year":"2009","journal-title":"J Intern Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/CVI.00221-07","article-title":"Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals","volume":"15","author":"NC Connolly","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/jmv.20612","article-title":"Peptide-loaded dendritic-cell vaccination followed by treatment interruption for chronic HIV-1 infection: a phase 1 trial","volume":"78","author":"F Ide","year":"2006","journal-title":"J Med Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/QAD.0b013e32832d9b00","article-title":"Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes","volume":"23","author":"H Kloverpris","year":"2009","journal-title":"AIDS"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1089\/aid.1998.14.551","article-title":"A pilot clinical trial of HIV antigen-pulsed allogeneic and autologous dendritic cell therapy in HIV-infected patients","volume":"14","author":"SK Kundu","year":"1998","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref26","article-title":"A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication","volume":"166","author":"F Garc\u00eda","year":"2013","journal-title":"Sci Transl Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1016\/j.vaccine.2011.07.043","article-title":"Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1","volume":"29","author":"F Garcia","year":"2011","journal-title":"Vaccine"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nature06175","article-title":"Taking dendritic cells into medicine","volume":"449","author":"RM Steinman","year":"2007","journal-title":"Nature"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1128\/JVI.79.6.3748-3757.2005","article-title":"Enhanced cellular immunity in macaques following a novel peptide immunotherapy","volume":"79","author":"S Chea","year":"2005","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.virol.2008.06.006","article-title":"Delivery of immunotherapy with peptide-pulsed blood in macaques","volume":"378","author":"R De Rose","year":"2008","journal-title":"Virology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-0684.2008.00329.x","article-title":"Safety, immunogenicity and efficacy of peptide-pulsed cellular immunotherapy in macaques","volume":"37 Suppl 2","author":"R De Rose","year":"2008","journal-title":"J Med Primatol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jim.2010.01.014","article-title":"Dimethyl sulfoxide (DMSO) exposure to human peripheral blood mononuclear cells (PBMCs) abolish T cell responses only in high concentrations and following coincubation for more than two hours","volume":"356","author":"H Kloverpris","year":"2010","journal-title":"J Immunol Methods"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1128\/CVI.00326-08","article-title":"Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continents","volume":"16","author":"MJ Boaz","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/nprot.2006.268","article-title":"Intracellular cytokine optimization and standard operating procedure","volume":"1","author":"L Lamoreaux","year":"2006","journal-title":"Nat Protoc"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e1000055","DOI":"10.1371\/journal.ppat.1000055","article-title":"Control of viremia and prevention of AIDS following immunotherapy of SIV-infected macaques with peptide-pulsed blood","volume":"4","author":"R De Rose","year":"2008","journal-title":"PLoS Pathog"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/nature03501","article-title":"Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection","volume":"434","author":"JJ Mattapallil","year":"2005","journal-title":"Nature"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1158\/1078-0432.CCR-08-0526","article-title":"CpG oligodeoxynucleotides alter lymphocyte and dendritic cell trafficking in humans","volume":"14","author":"WN Haining","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e29231","DOI":"10.1371\/journal.pone.0029231","article-title":"Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and\/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults","volume":"7","author":"SA Kalams","year":"2012","journal-title":"PLoS One"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1016\/j.vaccine.2005.10.035","article-title":"A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques","volume":"24","author":"EB Schadeck","year":"2006","journal-title":"Vaccine"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"15547","DOI":"10.1128\/JVI.79.24.15547-15555.2005","article-title":"Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag","volume":"79","author":"DR Casimiro","year":"2005","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1128\/JVI.00171-06","article-title":"Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239","volume":"80","author":"NA Wilson","year":"2006","journal-title":"J Virol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"12321","DOI":"10.1128\/JVI.79.19.12321-12331.2005","article-title":"Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys","volume":"79","author":"X Liang","year":"2005","journal-title":"J Virol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1086\/509258","article-title":"Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector","volume":"194","author":"AT Catanzaro","year":"2006","journal-title":"J Infect Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1086\/587993","article-title":"Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag\/pol\/nef vaccine in healthy adults","volume":"46","author":"FH Priddy","year":"2008","journal-title":"Clin Infect Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0074389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T03:49:43Z","timestamp":1540525783000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0074389"}},"subtitle":[],"editor":[{"given":"Alan","family":"Landay","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,4]]},"references-count":44,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0074389","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,4]]}}}